Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Korro Bio (KRRO) Current Leases (2020 - 2025)

Korro Bio (KRRO) has disclosed Current Leases for 6 consecutive years, with $3.1 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Current Leases changed N/A year-over-year to $3.1 million, compared with a TTM value of $3.1 million through Sep 2025, changed N/A, and an annual FY2024 reading of $1.3 million, down 35.51% over the prior year.
  • Current Leases was $3.1 million for Q3 2025 at Korro Bio, up from $2.4 million in the prior quarter.
  • Across five years, Current Leases topped out at $3.1 million in Q3 2025 and bottomed at $457000.0 in Q2 2024.
  • Average Current Leases over 5 years is $1.9 million, with a median of $1.8 million recorded in 2022.
  • The sharpest move saw Current Leases crashed 78.87% in 2024, then skyrocketed 430.63% in 2025.
  • Year by year, Current Leases stood at $1.7 million in 2021, then skyrocketed by 67.2% to $2.9 million in 2022, then plummeted by 31.84% to $2.0 million in 2023, then crashed by 35.51% to $1.3 million in 2024, then surged by 144.94% to $3.1 million in 2025.
  • Business Quant data shows Current Leases for KRRO at $3.1 million in Q3 2025, $2.4 million in Q2 2025, and $2.3 million in Q1 2025.